Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in Q1 2023

European Healthtech startup funding raised during Q1 2023.

In Q1 2023, 175 European Healthtech companies closed 177 funding rounds and raised €1.4B in equity funding (excluding debt and grants), down 35.0% versus Q1 2022. Debt rounds added €194M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€1.4B
-35.0% vs Q1 2022 · excl. debt & grants · +€194M debt
Funding rounds
177
+3.5% vs Q1 2022
Companies
175
Top country
UK
Rank among sectors
#3
10.4% of sector funding
Debt financing
€194M
11.9% of total
Top-10 round share
47.4%
of disclosed capital
Rounds ≥ €100M
4

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, Q1 2023 — interactive chart.
Data table
FundingRounds
Jan€538M66
Feb€580M54
Mar€517M57

Top countries

by € raised
Healthtech — top countries by capital, Q1 2023 — interactive chart.
Data table
Healthtech — top countries by capital, Q1 2023
UK€341M
Germany€273M
France€250M
Switzerland€227M
Denmark€181M
Italy€74M
Belgium€56M
Ireland€45M

Stage mix

by € raised
Healthtech — stage mix, Q1 2023 — interactive chart.
Data table
Healthtech — stage mix, Q1 2023
Other€425M
Series B€387M
Series C€281M
Debt€194M
Series A€150M
Seed€73M
Series D+€72M
Grant€38M
Pre-Seed€14M
Growth/Late€1.0M

Exits & M&A

17 Acquisition

17 exits · €170M disclosed.

VerogenAcquisitionJan 2023€140M
Diamond WhitesAcquisitionFeb 2023€30M

Top deals

largest disclosed rounds in Q1 2023
CompanyStageDateAmount
EvotecDebtFeb 2023€150M
Amolyt PharmaSeries CJan 2023€129M
Hemab TherapeuticsSeries BFeb 2023€127M
Noema PharmaSeries BMar 2023€105M
SoniVieSeries CJan 2023€56M
Grey Wolf TherapeuticsSeries BJan 2023€45M
MedwingSeries CMar 2023€44M
PeppySeries BJan 2023€42M
Lunaphore TechnologiesSeries D+Mar 2023€40M
EvosepOtherJan 2023€37M
PerspectumSeries CJan 2023€34M
OwkinGrantMar 2023€33M
XeltisSeries D+Feb 2023€32M
ProkariumOtherFeb 2023€28M
ExeVir BioDebtJan 2023€25M